Hodgkin Lymphoma and T-cell Lymphoma

Genetics and biology of classical Hodgkin Lymphoma: clinical implications
E. Tiacci
LECTURE I

Optimizing outcomes for CD19-directed CAR-T cell therapy in refractory B-cell lymphomas
S.J. Schuster
Mantle Cell Lymphoma

Biological identification of high risk Mantle Cell Lymphoma
C. Pott
How I treat relapsed/refractory Mantle Cell Lymphoma
C. Visco
LECTURE II

Impact of Lugano conferences in the lymphoma research
E. Zucca
Diffuse large B-Cell Lymphoma

How I treat high risk DLBCL in first line
A. Chiappella
Novel antibodies in aggressive lymphomas
M. Hutchings
Follicular Lymphoma

Biology of high risk Follicular Lymphoma
S. Ferrero
How I treat high risk Follicular Lymphoma in first line
W. Hiddemann
Chronic Lymphocytic Leukemia

Biology of high risk Chronic Lymphocytic Leukemia
M. Massaia
Multiple Myeloma

How I treat young high risk Multiple Myeloma
E. Zamagni
How I treat elderly high risk Multiple Myeloma
A. Larocca
LECTURE III

Myeloproliferative Disorders

Biology of high risk myeloproliferative disorders
P. Guglielmelli
How I treat high risk myeloproliferative neoplasms
D. Cilloni
Acute Lymphoblastic Leukemia and Transplantation

Biology of High Risk Acute Lymphoblastic Leukemia
J. Trka
How I treat high risk Acute Lymphoblastic Leukemia in first line
R. Bassan
Allogeneic transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndromes
N. Kroeger
Acute Myeloblastic Leukemia and Myelodysplastic Syndrome

Genomic identification of high risk Acute Myeloid Leukemia
B. Falini
How I treat high risk Myelodysplastic Syndromes
V. Santini
How I treat elderly Acute Myeloid Leukemia patients
A. Venditti
Privacy Policy | Cookie Policy